azacitidine and lenalidomide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for azacitidine and lenalidomide, covering 2019-10-08 to 2019-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia [Phase 2]